Latest Diabetes: Type II news

Risk Tool Can Predict Heart Failure in Patients With Diabetes

A novel machine learning-derived risk score can predict the risk for heart failure among outpatients with type 2 diabetes mellitus, according to a study published online Sept. 13 in Diabetes Care to coincide with the annual meeting of the Heart Failure Society of America, held from Sept. 13 to 16 in Philadelphia.

Dapagliflozin Lowers Risk for Worsening Heart Failure

For patients with heart failure and reduced ejection fraction, dapagliflozin is associated with a lower risk for worsening heart failure or death from cardiovascular causes, regardless of the presence of type 2 diabetes, according a study published online Sept. 19 in the New England Journal of Medicine. The research was published to coincide with the annual meeting of the European Association for the Study of Diabetes, held from Sept. 16 to 20 in Barcelona, Spain.

Linagliptin Noninferior for CV Risk in Early Type 2 Diabetes

Linagliptin is noninferior to glimepiride for adults with relatively early type 2 diabetes and elevated cardiovascular risk, according to a study published online Sept. 19 in the Journal of the American Medical Association to coincide with the annual meeting of the European Association for the Study of Diabetes, held from Sept. 16 to 20 in Barcelona, Spain.

Metabolic Surgery May Reduce CV Risk in T2DM With Obesity

For patients with type 2 diabetes and obesity, metabolic surgery is associated with a reduced risk for mortality and major adverse cardiovascular events, according to a study published online Sept. 2 in the Journal of the American Medical Association to coincide with the European Society of Cardiology Congress 2019, held from Aug. 31 to Sept. 4 in Paris.